Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
Author:
Constantine S Mitsiades,Nicholas S Mitsiades,Ciaran J McMullan,Vassiliki Poulaki,Reshma Shringarpure,Masaharu Akiyama,Teru Hideshima,Dharminder Chauhan,Marie Joseph,Towia A Libermann,Carlos Garcı́a-Echeverrı́a,Mark A Pearson,Francesco Hofmann et al.
Copyright © 2004 Cell Press. All rights reserved.